As of November 15, 2026, Absci Corp is a publicly traded company (Nasdaq: ABSI); its largest reported holder is BlackRock, with 7.8% on Schedule 13G/A of October 27, 2026, then ARK Invest (6.95%). The largest insider holding is Sean McClain, the chief executive and a director, with 8,552,402 shares (5.0% of shares outstanding), per Form 4 of October 30, 2026 (Schedule 13G/A, October 27, 2026).
Is this your company?
About to sign with, pay or invest in Absci Corp? See the free Snapshot first.
Free to see. No signup.
Is Absci Corp a real, registered company?
- Absci Corp files with the SEC under CIK 1672688 (its SEC filings).
- Its shares are listed under the ticker ABSI on Nasdaq (SEC company record).
- business address in Vancouver, Washington, as its SEC filings state.
- Court and bankruptcy records: see Before you sign or pay below.
Before you sign or pay
- Court and bankruptcy: No federal court case or bankruptcy filing found under Absci Corp in our court records and SEC 8-K records (as of 2026-11-15).
- Leadership changes: the latest reported is Andreas Busch, Chief Innovation Officer (Form 8-K filed 2026-03-06). Check you are dealing with the people now in charge.
- Ownership: 5%+ holders are reported on Schedule 13D or 13G; the latest names ARK Invest (filed 2026-11-13).
Who are Absci Corp's owners and officers?
Absci Corp: business address in Vancouver, Washington; industry Services-Commercial Physical & Biological Research (Schedule 13G/A, 2026-11-13).
| Report | Holder | Share |
|---|---|---|
| Schedule 13G/A, 2026-11-13 | Ark Investment Management LLC | 6.95% |
| Schedule 13G/A, 2026-10-27 | Blackrock, Inc. | 7.8% |
| Schedule 13D/A, 2026-04-14 | Redmile Group, LLC | 4.9% |
| Schedule 13G/A, 2026-03-26 | The Vanguard Group | 0% |
| Schedule 13D/A, 2026-03-26 | Redmile Group, LLC | 5.4% |
| Schedule 13G, 2026-01-30 | The Vanguard Group | 5.26% |
| Schedule 13G/A, 2025-11-13 | Sean Mcclain | 7.2% |
| Schedule 13G/A, 2025-10-30 | The Vanguard Group | 4.87% |
| Schedule 13G, 2025-07-29 | The Vanguard Group | 5.05% |
| Schedule 13G/A, 2025-07-16 | Blackrock, Inc. | 6.5% |
Questions about who owns Absci Corp
Who owns Absci Corp?
On this page, 3 holders' latest ownership filings report 5% or more of Absci Corp: Blackrock, Inc. (7.8%, Schedule 13G/A, filed 2026-10-27), Sean Mcclain (7.2%, Schedule 13G/A, filed 2025-11-13) and Ark Investment Management LLC (6.95%, Schedule 13G/A, filed 2026-11-13).
Who are the largest shareholders of Absci Corp?
By the share each holder's latest filing reports, the largest holders of Absci Corp on this page are Blackrock, Inc. (7.8%), Sean Mcclain (7.2%) and Ark Investment Management LLC (6.95%).
When did Blackrock, Inc. buy into Absci Corp?
The filings give report dates, not purchase dates. The earliest filing from Blackrock, Inc. on this page is the Schedule 13G/A, filed 2025-07-16, reporting 6.5%; its latest, Schedule 13G/A filed 2026-10-27, reports 7.8%. That earliest filing is itself an amendment, which updates an earlier report.
Is this an audit or a full list?
Neither. The ownership list on this page covers only Schedule 13D and 13G filings, which holders make once they own 5% or more of a class of shares (an amendment can report a stake that has since fallen below 5%); 10 such filings are shown here. It is not an audit and not a full cap table: holders who never reached 5% are not listed, and a stake can change after its latest filing.
Want the whole picture on Absci Corp?
Example from a real report (our sample on Target): “The Q2 2026 earnings report, published August 19, 2026, showed adjusted EPS of $2.46 against an expected $2.33” Source: CNBC
A Full Report on Absci Corp: verified, sourced, every claim cited, ready in a few minutes. See pricing.
What the Full Report on Absci Corp covers
The Short Answer
Which Company This Is
What They Do, And How The Money Works
Who Runs It, And How To Reach Them
The Money: Funding, Valuation, Runway
Who Pays Them, And Who They Are Up Against
Warning Bells
Sources
17 cited sources found
Plus the sections for what you are deciding, which you pick after ordering.
A real finished report, first screen. Opens in a new tab.
| Filed | Person | Role | Change | Effective |
|---|---|---|---|---|
| Form 8-K, 2026-03-06 | Andreas Busch | Chief Innovation Officer | departed | 2026-03-31 |
Which insiders own Absci Corp shares?
Directors, officers and holders of 10% or more report their shares on Forms 3, 4 and 5. Each line is the latest such report, largest holding first.
- , the chief executive and a director: 8,552,402 shares (5.0% of shares outstanding) (Form 4, 2026-10-30).
- , the chief financial officer and cbo: 484,918 shares (0.28% of shares outstanding) (Form 4, 2026-10-14).
- , the chief innovation officer: 421,446 shares (0.24% of shares outstanding) (Form 4, 2026-03-16).
- , a director: 242,408 shares (0.14% of shares outstanding) (Form 4, 2026-06-08).
- , the senior vice president and cao: 199,128 shares (0.12% of shares outstanding) (Form 4, 2026-10-14).
Shares outstanding: 172,745,810 as of 2026-10-30, from the company's latest SEC cover page.
How much has Absci Corp raised?
No fundraising or offering filing from Absci Corp is on file with us.
Keep reading
More on Absci Corp and the records around it.
Absci Corp elsewhere on the record
- Leadership changes Mar 2026
Companies that share a holder
- Redmile Group, LLC also filed stake reports on 18 other companies: FATE THERAPEUTICS INC (Nov 2026), Electra Therapeutics, Inc. (Sep 2026), Neurogene Inc. (Aug 2026)
- ARK Investment Management LLC also filed stake reports on 23 other companies: Beam Therapeutics Inc. (Nov 2026), CERUS CORP (Nov 2026), CRISPR Therapeutics AG (Nov 2026)
- BlackRock, Inc. also filed stake reports on 1596 other companies: AvePoint, Inc. (Nov 2026), BIOMARIN PHARMACEUTICAL INC (Nov 2026), MSG RANGERS CORP (Nov 2026)
Related pages
Filings, cases and notices link to their records. A not-found line names the records searched; it is not proof of absence.
Not for employment, credit, insurance or tenancy decisions.
Cite this page
https://mentionfox.com/who-owns/absci